-
Fund Dashboard
- Holdings
Eventide Healthcare & Life Sciences Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
MIRM Mirum Pharmaceuticals, Inc. | 64.97 mm | 1.67 mm shares | 4.35 | Common equity | Long | USA |
US BANK MMDA - USBGFS 9 | 52.15 mm | 52.15 mm principal | 3.49 | Short-term investment vehicle | Long | USA |
AURA Aura Biosciences, Inc. | 51.70 mm | 5.80 mm shares | 3.46 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 49.66 mm | 1.29 mm shares | 3.33 | Common equity | Long | USA |
INSM Insmed Incorporated | 49.29 mm | 675.19 k shares | 3.30 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 46.10 mm | 1.36 mm shares | 3.09 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 43.82 mm | 383.45 k shares | 2.94 | Common equity | Long | USA |
EVH Evolent Health, Inc. | 40.87 mm | 1.45 mm shares | 2.74 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 38.52 mm | 565.55 k shares | 2.58 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 37.56 mm | 735.09 k shares | 2.52 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 34.72 mm | 386.33 k shares | 2.33 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 34.09 mm | 272.95 k shares | 2.28 | Common equity | Long | USA |
TMDX TransMedics Group, Inc. | 33.60 mm | 214.00 k shares | 2.25 | Common equity | Long | USA |
GH Guardant Health, Inc. | 33.32 mm | 1.45 mm shares | 2.23 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 33.30 mm | 4.83 mm shares | 2.23 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 32.25 mm | 348.70 k shares | 2.16 | Common equity | Long | USA |
GERN Geron Corporation | 32.11 mm | 7.07 mm shares | 2.15 | Common equity | Long | USA |
VRNA Verona Pharma plc | 28.84 mm | 1.00 mm shares | 1.93 | Common equity | Long | UK |
VKTX Viking Therapeutics, Inc. | 28.68 mm | 452.97 k shares | 1.92 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 26.40 mm | 125.09 k shares | 1.77 | Common equity | Long | USA |
NARI Inari Medical, Inc. | 25.55 mm | 619.65 k shares | 1.71 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 24.31 mm | 67.83 k shares | 1.63 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 24.04 mm | 507.90 k shares | 1.61 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 23.93 mm | 87.00 k shares | 1.60 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 23.72 mm | 523.05 k shares | 1.59 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 23.08 mm | 677.88 k shares | 1.55 | Common equity | Long | USA |
CELC Celcuity Inc. | 22.89 mm | 1.54 mm shares | 1.53 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 22.07 mm | 380.00 k shares | 1.48 | Common equity | Long | USA |
INZY Inozyme Pharma, Inc. | 21.62 mm | 4.13 mm shares | 1.45 | Common equity | Long | USA |
IRTC iRhythm Technologies, Inc. | 20.20 mm | 272.09 k shares | 1.35 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 19.98 mm | 399.83 k shares | 1.34 | Common equity | Long | Virgin Islands (British) |
RCM R1 RCM Inc. | 19.50 mm | 1.38 mm shares | 1.31 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 18.99 mm | 2.68 mm shares | 1.27 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 18.21 mm | 4.95 mm shares | 1.22 | Common equity | Long | USA |
RGEN Repligen Corporation | 17.71 mm | 119.00 k shares | 1.19 | Common equity | Long | USA |
ARGX argenx SE | 17.51 mm | 32.31 k shares | 1.17 | Common equity | Long | Netherlands |
KRYS Krystal Biotech, Inc. | 17.44 mm | 95.78 k shares | 1.17 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 17.27 mm | 375.92 k shares | 1.16 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 16.81 mm | 718.81 k shares | 1.13 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 15.15 mm | 786.99 k shares | 1.01 | Common equity | Long | USA |
Avalyn Pharma | 15.00 mm | 20.48 mm shares | 1.00 | Preferred equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 14.75 mm | 579.41 k shares | 0.99 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 14.23 mm | 770.69 k shares | 0.95 | Common equity | Long | USA |
SHORELINE BIOSCIENCES B | 14.01 mm | 1.49 mm shares | 0.94 | Preferred equity | Long | USA |
LXEO Lexeo Therapeutics, Inc. Common Stock | 13.79 mm | 1.53 mm shares | 0.92 | Common equity | Long | USA |
PRVA Privia Health Group, Inc. | 13.43 mm | 737.69 k shares | 0.90 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 13.42 mm | 254.15 k shares | 0.90 | Common equity | Long | USA |
KORRO BIO INC.
|
12.34 mm | 369.11 k shares | 0.83 | Common equity | Long | USA |
NKTR Nektar Therapeutics | 12.22 mm | 9.40 mm shares | 0.82 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 11.94 mm | 332.28 k shares | 0.80 | Common equity | Long | USA |
SILENCE THER-ADR
|
11.64 mm | 640.00 k shares | 0.78 | Common equity | Long | UK |
IDYA IDEAYA Biosciences, Inc. | 10.61 mm | 335.00 k shares | 0.71 | Common equity | Long | USA |
PRCT PROCEPT BioRobotics Corporation | 10.34 mm | 129.00 k shares | 0.69 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 9.93 mm | 919.64 k shares | 0.67 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 8.88 mm | 577.50 k shares | 0.60 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 8.84 mm | 263.75 k shares | 0.59 | Common equity | Long | USA |
QTTB Q32 Bio Inc. | 8.48 mm | 190.00 k shares | 0.57 | Common equity | Long | USA |
GKOS Glaukos Corporation | 8.28 mm | 63.54 k shares | 0.55 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 8.18 mm | 1.02 mm shares | 0.55 | Common equity | Long | USA |
Kestra Medical Tech | 8.00 mm | 545.33 k shares | 0.54 | Preferred equity | Long | USA |
DVAX Dynavax Technologies Corporation | 7.51 mm | 673.81 k shares | 0.50 | Common equity | Long | USA |
BETA BIONIC SERIES B | 7.04 mm | 940.66 k shares | 0.47 | Preferred equity | Long | USA |
BETA BIONICS B2 | 6.16 mm | 809.36 k shares | 0.41 | Preferred equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 4.57 mm | 422.86 k shares | 0.31 | Common equity | Long | USA |
BETA BIONICS INC SERIES D
|
4.41 mm | 476.19 k shares | 0.30 | Common equity | Long | USA |
Beta Bionics Inc | 3.57 mm | 482.03 k shares | 0.24 | Preferred equity | Long | USA |
BRIDGEBIO PHARMA
|
3.50 mm | 137.51 k shares | 0.23 | Common equity | Long | USA |
FID-MM GOVT-I | 3.44 mm | 3.44 mm principal | 0.23 | Short-term investment vehicle | Long | USA |
LEXEO THERAPEUTICS
|
2.99 mm | 330.47 k shares | 0.20 | Common equity | Long | USA |
FLARE THERAPEUTICS | 2.35 mm | 1.95 mm shares | 0.16 | Preferred equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 2.26 mm | 110.40 k shares | 0.15 | Common equity | Long | USA |
BETA BIONICS CL D WARRANT | 2.23 mm | 333.33 k shares | 0.15 | DO | Long | USA |
Freenome Holdings | 1.53 mm | 930.44 k shares | 0.10 | Preferred equity | Long | USA |
FLARE THERAPEUTI | 1.32 mm | 1.10 mm shares | 0.09 | Preferred equity | Long | USA |
PELOTON THERAPEU | 1.29 mm | 1.53 mm shares | 0.09 | Preferred equity | Long | USA |
Flare Series A Tranche 2 | 1.09 mm | 902.44 k shares | 0.07 | Preferred equity | Long | USA |
BETA BIONICS INC SERIES C | 891.70 k | 120.50 k shares | 0.06 | DO | Long | USA |
KRRO Korro Bio, Inc. | 737.18 k | 22.06 k shares | 0.05 | Common equity | Long | USA |
EVIDA BIOSCIENCES INC | 702.26 k | 1.02 mm shares | 0.05 | Preferred equity | Long | USA |
CASMA THERAPEUTI | 523.25 k | 5.00 mm shares | 0.04 | Preferred equity | Long | USA |
CASMA SER B2 | 523.25 k | 5.00 mm shares | 0.04 | Preferred equity | Long | USA |
Kojin Therapeutics | 467.23 k | 763.32 k shares | 0.03 | Preferred equity | Long | USA |
KOJIN THERAPEUTICS INC | 467.23 k | 763.32 k shares | 0.03 | Preferred equity | Long | USA |
BISPL F 03/12/2025 | 394.52 k | 3.50 mm principal | 0.03 | Debt | Long | USA |
Freenome | 219.69 k | 133.94 k shares | 0.01 | Preferred equity | Long | USA |
CASMA THERAPEUTICS II | 207.19 k | 1.98 mm shares | 0.01 | Preferred equity | Long | USA |
CASMA THERAPEUTICS | 190.51 k | 1.82 mm shares | 0.01 | Preferred equity | Long | USA |
ARCH ONCOLOGY IN | 128.80 k | 4.64 mm shares | 0.01 | Preferred equity | Long | USA |
Biosplice Therapeutics | 0 | 104.78 k shares | 0.00 | DO | Long | USA |
BioSplice Therapeutics | 0 | 295.28 k shares | 0.00 | Preferred equity | Long | USA |
GOLDFINCH BIOPHARMA INC | 0 | 5.00 mm shares | 0.00 | Preferred equity | Long | USA |
GOLDFINCH BIOPHARMA INC B | 0 | 8.47 mm shares | 0.00 | Preferred equity | Long | USA |
GOLDFINCH BIO B2 | 0 | 4.24 mm shares | 0.00 | Preferred equity | Long | USA |